News | June 23, 2015

Extensive survey finds most users value ease of use and functionality, prefer bundling systems

ECRI Institute, linear accelerators, linac, purchase, survey

June 23, 2015 - The ECRI Institute released a new techIQ brief on key factors to consider when purchasing a linear accelerator (linac) for external beam radiation therapy. The report is a compilation of results from a survey of hundreds of users of linac-based radiosurgery systems; participants were asked to rate the functions and features of the four major linac vendors: Accuray, Brainlab, Elekta and Varian Medical Systems.

Among the factors considered were:

  • Ease of use;
  • Functionality;
  • Reliability;
  • Siting requirements;
  • Implementation;
  • Service;
  • Vendor support;
  • Training; and
  • Cost

 

According to the survey results, the linac models with the highest overall ratings scored the highest for ease of use, functionality, imaging capabilities and device interoperability.

ECRI also sought to determine the different ways that linacs are employed. The survey found that nearly half of all respondents typically utilize their linac for both standard radiotherapy and stereotactic radiosurgery.

Fifty-nine percent of those surveyed use a treatment planning system and linac from the same manufacturer, and 47 percent use an oncology information system that is also sold by the linac manufacturer. This bundling of systems and services has been a growing trend in the marketplace over the past few years, offering benefits such as higher equipment discounts, reduced training expenses and coinciding service contracts.

The ECRI Institute is an independent nonprofit organization that conducts research into the most effective approaches for improving patient care.  

For more information: www.ecri.org


Related Content

News | Quality Assurance (QA)

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery ...

Time March 16, 2023
arrow
News | Radiation Oncology

March 14, 2023 — Elekta announced that is has signed a joint venture with China National Pharmaceutical Group Co., Ltd. ...

Time March 14, 2023
arrow
News | Radiation Oncology

March 3, 2023 — RefleXion Medical, Inc., a therapeutic oncology company, announced the installation of its RefleXion X1 ...

Time March 03, 2023
arrow
News | Radiation Therapy

February 28, 2023 — Elekta announced that Comprehensive Motion Management (CMM) with True Tracking and automatic gating ...

Time February 28, 2023
arrow
News | Radiation Oncology

February 17, 2023 — Derry Crighton, a father of three from Scotland, says the Elekta Esprit radiosurgery system used to ...

Time February 17, 2023
arrow
News | Radiation Therapy

February 16, 2023 — TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation ...

Time February 16, 2023
arrow
News | Radiation Oncology

February 7, 2023 — During World Cancer Day (February 4), the Elekta Foundation celebrated its first year by highlighting ...

Time February 07, 2023
arrow
News | Radiation Oncology

February 7, 2023 — Primary lung neuroendocrine tumors are very rare tumors that represent about 1-2% of all lung cancer ...

Time February 07, 2023
arrow
News | Radiation Therapy

February 6, 2023 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time February 06, 2023
arrow
Feature | ASTRO | Christine Book

The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the American Society for ...

Time January 13, 2023
arrow
Subscribe Now